Kratom Lobby Petitions FDA After Agency Issues Consumer Warning

November 17, 2017 at 3:17 PM
FDA's recent alert on alleged health risks associated with the herbal product kratom is being challenged by the American Kratom Association, which is petitioning the agency under the Information Quality Act to set up a special advisory committee of independent experts to review the accuracy and integrity of the data underlying FDA's advisory, and to hold a public meeting on the product. This is not the first time an agency's attempt to restrict access to kratom, an herbal product popular...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.